Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair.
暂无分享,去创建一个
A. Nusrat | C. Parkos | S. Flemming | J. Brazil | Miguel Quirós | V. Azcutia | Arturo Raya-Sandino | Matthias Kelm | Dorothee Birkl | Jael Miranda | Vicky García‐Hernández | Vicky Garcia-Hernandez
[1] Chenzhe Feng,et al. Trends in Worldwide Research in Inflammatory Bowel Disease Over the Period 2012–2021: A Bibliometric Study , 2022, Frontiers in Medicine.
[2] Fabrice Daian,et al. The Scf/Kit pathway implements self-organized epithelial patterning. , 2021, Developmental cell.
[3] N. Lukacs,et al. Stem Cell Factor Neutralization Protects From Severe Anaphylaxis in a Murine Model of Food Allergy , 2021, Frontiers in Immunology.
[4] S. Koch,et al. Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model. , 2021, Journal of visualized experiments : JoVE.
[5] Andrés J. García,et al. Desmocollin-2 promotes intestinal mucosal repair by controlling integrin-dependent cell adhesion and migration , 2020, Molecular biology of the cell.
[6] J. Gisbert,et al. Predictors of primary response to biologic treatment (anti-TNF, vedolizumab and ustekinumab) in patients with inflammatory bowel disease: from basic science to clinical practice. , 2019, Journal of Crohn's & colitis.
[7] S. Kunkel,et al. Inhibition of the Stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease. , 2019, American journal of physiology. Lung cellular and molecular physiology.
[8] A. Nusrat,et al. Epithelial CD47 is critical for mucosal repair in the murine intestine in vivo , 2019, Nature Communications.
[9] T. H. Nguyen,et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.
[10] N. Lukacs,et al. Group 2 innate lymphoid cells (ILC2) are regulated by stem cell factor during chronic asthmatic disease , 2018, Mucosal Immunology.
[11] H. Clevers,et al. Paneth Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stem-like Features through SCF/c-Kit Signaling. , 2018, Cell reports.
[12] Guilan Li,et al. SCF/c-KIT signaling promotes mucus secretion of colonic goblet cells and development of mucinous colorectal adenocarcinoma. , 2018, American journal of cancer research.
[13] Guilan Li,et al. SCF/c-KIT Signaling Increased Mucin2 Production by Maintaining Atoh1 Expression in Mucinous Colorectal Adenocarcinoma , 2018, International journal of molecular sciences.
[14] D. Repsilber,et al. Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles , 2017, PloS one.
[15] T. Denning,et al. Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling. , 2017, The Journal of clinical investigation.
[16] L. Peyrin-Biroulet,et al. Ulcerative colitis , 2017, The Lancet.
[17] James M. Dahlhamer,et al. Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015. , 2016, MMWR. Morbidity and mortality weekly report.
[18] C. Fiocchi,et al. Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.
[19] O. Farokhzad,et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. , 2015, The Journal of clinical investigation.
[20] F. Cominelli,et al. Targeting Leukocyte Trafficking for the Treatment of Inflammatory Bowel Disease , 2015, Clinical pharmacology and therapeutics.
[21] J. Huizinga,et al. Interstitial Cells of Cajal: Pathology, injury and repair. , 2012, Sultan Qaboos University medical journal.
[22] Johan Lennartsson,et al. Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.
[23] P. Secchiero,et al. JCV+ Patients with Inflammatory bowel disease show elevated plasma levels of MIG and SCF. , 2012, Inflammatory bowel diseases.
[24] S. Quake,et al. Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. , 2012, Gastroenterology.
[25] J. Flanagan,et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.
[26] D. C. Cara,et al. Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF): a chemoattractive agent for murine leukocytes in vivo , 2011, Journal of leukocyte biology.
[27] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[28] D. Margulies,et al. Surface Binding Inhibitors of the SCF–KIT Protein–Protein Interaction , 2009, Chembiochem : a European journal of chemical biology.
[29] E. Carter,et al. Epidermal stem cell factor augments the inflammatory response in irritant and allergic contact dermatitis. , 2008, The Journal of investigative dermatology.
[30] L. Reber,et al. Stem cell factor expression, mast cells and inflammation in asthma , 2006, Fundamental & clinical pharmacology.
[31] Daniel Metzger,et al. Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium , 2004, Genesis.
[32] R. Olivenstein,et al. The expression of stem cell factor and c‐kit receptor in human asthmatic airways , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[33] P. Lincoln,et al. Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses , 2004, Clinical and experimental immunology.
[34] F. Cavalli,et al. A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia. , 2003, Blood.
[35] A. Ullrich,et al. Beyond Herceptin and Gleevec. , 2003, Current opinion in chemical biology.
[36] G. Bouma,et al. The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.
[37] J. Malm,et al. Expression of the neutrophil‐activating CXC chemokine ENA‐78/CXCL5 by human eosinophils , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[38] J. Soboloff,et al. Mast cells stimulated by membrane-bound, but not soluble, steel factor are dependent on phospholipase C activation , 2003, Cellular and Molecular Life Sciences CMLS.
[39] F. Levi-Schaffer,et al. Human peripheral blood eosinophils express stem cell factor. , 2001, Blood.
[40] M. Neurath,et al. Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma. , 2001, The Journal of allergy and clinical immunology.
[41] K. Zsebo,et al. Measurement of Human and Murine Stem Cell Factor (c‐kit Ligand) , 1992, Current protocols in immunology.
[42] Yaping Chen,et al. Insights from mouse models of colitis , 2000, Journal of leukocyte biology.
[43] Grabbe,et al. Human Mast Cells Produce and Differentially Express Both Soluble and Membrane‐Bound Stem Cell Factor , 1999, Scandinavian journal of immunology.
[44] A. Imaoka,et al. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain , 1998, Gut.
[45] D. Metcalfe,et al. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. , 1997, The Journal of clinical investigation.
[46] J. Abrams,et al. A role for stem cell factor (SCF): c-kit interaction(s) in the intestinal tract response to Salmonella typhimurium infection , 1996, The Journal of experimental medicine.
[47] D. Taub,et al. Stem cell factor (c-kit ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation. , 1996, Journal of immunology.
[48] D. Taub,et al. The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. , 1996, Blood.
[49] J. Peterson,et al. A role for stem cell factor and c-kit in the murine intestinal tract secretory response to cholera toxin , 1995, The Journal of experimental medicine.
[50] M. Neurath,et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice , 1995, The Journal of experimental medicine.
[51] J. Abkowitz,et al. Stem cell factor production by human marrow stromal fibroblasts. , 1995, Experimental hematology.
[52] C. Elson,et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.
[53] D. Williams,et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. , 1993, The New England journal of medicine.
[54] R. Braun,et al. Human peripheral blood eosinophils produce and release interleukin‐8 on stimulation with calcium ionophore , 1993, European journal of immunology.
[55] M. Heinrich,et al. Constitutive expression of steel factor gene by human stromal cells. , 1993, Blood.
[56] S. Nishikawa,et al. Requirement of c-kit for development of intestinal pacemaker system. , 1992, Development.
[57] David A. Williams,et al. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor , 1990, Cell.
[58] P. Leder,et al. The kit ligand: A cell surface molecule altered in steel mutant fibroblasts , 1990, Cell.
[59] C. March,et al. Identification of a ligand for the c-kit proto-oncogene , 1990, Cell.
[60] M. Baggiolini,et al. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.
[61] A. Bernstein,et al. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. , 1989, Genes & development.
[62] J. Wallace,et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.